Clinical Trials on Pneumonia, Pneumococcal

Total 9896 results

Centre Hospitalier Universitaire Dijon

Completed

Identification and Quantification of Immune Response Induced by Hyaluronidase and Other Factors of Virulence of Invasive Human Infections of Streptococcus Pneumoniae (Hyalo strepto)

Invasive Pneumococcic

France
Pfizer

Completed

Serotype Distribution of Streptococcus Pneumoniae That Causes Invasive Diseases at Children and Adults in Turkey

Pneumococcal Diseases

Turkey
London School of Hygiene and Tropical Medicine
University College, London; Bill and Melinda Gates Foundation; Wellcome Trust; KEMRI-Wellcome... and other collaborators

Active, not recruiting

The Effect of Fractional Doses of Pneumococcal Conjugate Vaccines on Immunogenicity and Carriage in Kenyan Infants (FPCV)

Pneumococcal Infection | Streptococcus Pneumoniae Infection | Invasive Pneumococcal Disease, Protection Against

Kenya
Sanofi Pasteur, a Sanofi Company

Completed

Study of an Investigational Pneumococcal Vaccine at Three Dose Levels in Healthy Adults

Pneumococcal Infections | Streptococcus Pneumoniae Infections | Pneumococcal Pneumonia

Switzerland
University of British Columbia
Canadian Institutes of Health Research (CIHR); University of Calgary; Alberta... and other collaborators

Completed

CIRN Pneumococcal Conjugate Vaccine 1 vs. 2 Dose Priming Study

Streptococcus Pneumoniae Infection | Invasive Pneumococcal Disease, Protection Against

Canada
Liverpool School of Tropical Medicine

Not yet recruiting

Experimental Pneumococcal Carriage in People Living With HIV

Hiv | Pneumococcus; Pneumonia

Malawi
Sanofi

Completed

Study of Two Investigational Pneumococcal Vaccines in Healthy Adults

Pneumococcal Infections | Streptococcus Pneumoniae Infections | Pneumococcal Pneumonia

Switzerland
Pfizer

Completed

Prevenar Special Use-result Surveillance in Japan (Regulatory PostMarketing Commitment Plan)

Streptococcus Pneumoniae | Pneumococcal Vaccine

Japan
Pfizer

Completed

Nasopharyngeal Streptococcus Pneumoniae Carriage

Streptococcus Pneumoniae Infections

Taiwan
UMC Utrecht
Netherlands: Ministry of Health, Welfare and Sports; Netherlands Vaccine Institute

Completed

Effect of Two Versus Three Pneumococcal Conjugate Vaccinations (MNOES)

Streptococcus Pneumoniae Infection
University of Colorado, Denver
Pfizer

Completed

Determination of the Utility of Pfizer's Pneumococcal Urine Antigen Test in Children 5 Years of Age or Younger With Community Acquired Pneumonia in Guatemala

Community-acquired Pneumonia | Streptococcus Pneumoniae Infection

Guatemala
University of Oxford
Pfizer

Unknown

Understanding Pneumococcal Carriage and Disease 2017-2020

Streptococcal Pneumonia | Streptococcus Pneumoniae Infection | Streptococcus Pneumoniae, Invasive Disease

United Kingdom
Wyeth is now a wholly owned subsidiary of Pfizer

Completed

Prevalence of Nasopharyngeal Carriage of Streptococcus Pneumoniae in Healthy Children of 12-18 Months in 6 Cities, China

Streptococcus Pneumoniae Infections

China
PATH Vaccine Solutions

Completed

Phase I Safety Trial of Streptococcus Pneumoniae Whole Cell Vaccine (SPWCV) + Alum in Healthy Adults

Pneumococcal Vaccines

United States
Universidad de la Sabana

Recruiting

Pneumococcal Nasopharyngeal Colonization as Predictor of Community-Acquired Pneumonia (CAP) in Adults With Chronic Diseases. (CAP)

Community-acquired Pneumonia | Streptococcus Pneumoniae Infection | Streptococcus Pneumoniae Pneumonia | Streptococcus Pneumoniae Infection Invasive

Colombia
GlaxoSmithKline

Completed

Study to Evaluate the Response Rate to the Licensed Pneumovax 23™ in Elderly Population.

Streptococcus Pneumoniae Vaccines

Sweden
GlaxoSmithKline

Completed

Primary Vaccination With Either Synflorix™ or Prevenar 13™ or Both Vaccines and Booster Vaccination With Synflorix™

Streptococcus Pneumoniae Vaccines | Infections, Streptococcal

Mexico
Arto Palmu
GlaxoSmithKline

Completed

Effects of Pneumococcal Vaccine on Nasopharyngeal Carriage

Nasopharyngeal Carriage of Streptococcus Pneumoniae

Finland
Boston Medical Center
Merck Sharp & Dohme LLC

Completed

Streptococcus Pneumonia: Effects of PCV13 on Pneumococcal Carriage

Nasopharyngeal Carriage of S. Pneumoniae

United States
GlaxoSmithKline

Withdrawn

Post-marketing Safety Study of GlaxoSmithKline (GSK) Biologicals' Synflorix™ Vaccine, in Healthy Infants and Children in Sri Lanka

Immunisation Against Streptococcus Pneumoniae
University of Liverpool
University College, London; World Health Organization; Liverpool School of Tropical... and other collaborators

Recruiting

An Evaluation of PCV13 Vaccine Schedules, Comparing Impact of 2+1 vs 3+0 on Pneumococcal Carriage in Blantyre, Malawi (PAVE)

Streptococcus Pneumoniae | 13-valent Pneumococcal Vaccine

Malawi
Walvax Biotechnology Co., Ltd.

Completed

Immunogenicity and Safety Study of the 13-valent Pneumococcal Polysaccharide Conjugate Vaccine in 2-71 Months Old Healthy Infants and Toddlers (the Youngest Could be 6 Weeks Old)

Diseases Caused by Streptococcus Pneumoniae Serotypes
GlaxoSmithKline

Completed

Primary Vaccination Study With a Pneumococcal Conjugate Vaccine in Healthy Children 6 to 12wks of Age

Streptococcus Pneumoniae Vaccines | Infections, Streptococcal

Mexico
GlaxoSmithKline

Completed

Primary Vaccination Study With GSK Biologicals' Pneumococcal Vaccine in Healthy Infants in Vietnam

Streptococcus Pneumoniae Vaccines | Infections, Streptococcal

Vietnam
GlaxoSmithKline

Completed

Assess the Immunogenicity of GSK Biologicals' 10-valent Pneumococcal Conjugate Vaccine

Streptococcus Pneumoniae Vaccines | Infections, Streptococcal

Germany
University of Milan

Unknown

Longitudinal Pattern of Streptococcus Pneumoniae Nasopharyngeal Carriage and Antimicrobial Susceptibility in Healthy Children Aged Less Then 5 Years, in the Area of Milan and Surroundings, Lombardy, Italy.

Streptococcus Pneumoniae Nasopharyngeal Carriage

Italy
Liverpool School of Tropical Medicine
Merck Sharp & Dohme LLC

Recruiting

Experimental Human Pneumococcal Challenge With SPN3 (Challenge3)

Streptococcus Pneumonia

United Kingdom
Azienda Ospedaliera di Lecco
IRCCS Ospedale San Raffaele

Not yet recruiting

Evaluation of Vaccination for Streptococcus Pneumoniae in Adults With an Episode of Invasive Pneumococcal Infection. (pVax)

Invasive Pneumococcal Infection
Liverpool School of Tropical Medicine
Pfizer

Recruiting

PREVENTING PNEUMOcoccal Disease Through Vaccination (Study 2) (Pneumo 2)

Streptococcus Pneumonia

United Kingdom
Chinese University of Hong Kong

Recruiting

Evaluation of Streptococcus Pneumoniae Serotypes Prevalence Using a Urinary Kit

Community-acquired Pneumonia

Hong Kong
GlaxoSmithKline

Completed

Assessment of Antibody Persistence in Children Previously Vaccinated With Pneumococcal Conjugate Vaccine

Streptococcus Pneumoniae Vaccines | Infections, Streptococcal

Poland
Dr Cipto Mangunkusumo General Hospital
Eijkman Institute for Molecular Biology

Completed

Prevalence and Serotype of Streptococcus Pneumoniae Hospitalized Adult With Community-Acquired Pneumonia (HACAP)

Pneumonia, Bacterial

Indonesia
Instituto de Atención Pediátrica
Pfizer; Ben-Gurion University of the Negev

Suspended

Costa Rica Epidemiological Study on S. Pneumoniae

Streptococcus Pneumoniae

Costa Rica
Public Health England

Completed

Evaluation of the Immunogenicity and Reactogenicity of a Pneumococcal Conjugate Vaccine in Healthy Adults

Streptococcus Pneumoniae
Arizona State University

Completed

Recombinant Attenuated Salmonella Typhi Vaccine Vectors Producing Streptococcus Pneumoniae PspA

Pneumonia

United States
Radboud University Medical Center

Completed

A Controlled Human Pneumococcal Infection Model (PIM) Study (PIM)

Streptococcus Pneumoniae Infection

Netherlands
Methodist Health System

Recruiting

Short Versus Long Duration of Therapy for Streptococcus Pneumoniae Bloodstream Infections

Streptococcus Pneumoniae

United States
Combioxin SA

Completed

Safety, Tolerability, Efficacy and Pharmacodynamics of CAL02 in Severe Pneumonia Caused by Streptococcus Pneumoniae

Pneumonia | Pneumococcal Infections

France, Belgium
Prof. Elizabeth Miller

Completed

Evaluating Vaccine Responses in Healthy Infants Receiving Their Routine Primary Immunisation According to the Accelerated United Kingdom Schedule at 2, 3 and 4 Months (P13UK)

Streptococcus Pneumoniae

United Kingdom
Public Health England

Completed

Immunogenicity of a Reduced Primary Schedule for Pneumococcal Conjugate Vaccine in UK Infants

Streptococcus Pneumoniae
Sanofi Pasteur, a Sanofi Company

Completed

Immunogenicity and Safety of a Booster Dose of Pneumo 23® in 12 to 18 Months-Old Children Primed With Prevnar

Streptococcus Pneumoniae

Thailand
Department of Clinical Research and Innovation

Unknown

Streptococcus Pneumoniae Nasopharyngeal Carriage

Nursery

France
Johns Hopkins Bloomberg School of Public Health

Completed

AMR of Streptococcus Pneumoniae Carriage Strains

Infection
Centre Hospitalier Universitaire de Nīmes

Recruiting

Prevention of Pneumococcal Infections: Impact Collaborative Medico-pharmaceutical Care Structured to Improve Vaccination Coverage of Patients at Risk. (OPTIVACC)

Streptococcus Pneumoniae Infection

France
Sanofi Pasteur, a Sanofi Company

Completed

Study of Investigational Pneumococcal Vaccine in Healthy Adults, Toddlers and Infants

Pneumonia | Pneumococcal Infections | Streptococcus Pneumoniae Infections

Bangladesh
VA Office of Research and Development
Michael E. DeBakey VA Medical Center

Completed

Humoral Determinants of Immunity to Pneumococcal Infection

Pneumonia | Pneumococcal Infections | Infections, Streptococcus Pneumoniae

United States
Finnish Institute for Health and Welfare
Turku University Hospital; GlaxoSmithKline

Completed

Immunity to Serotype 19A Streptococcus Pneumoniae in Children Vaccinated With PCV10

Pneumococcal Infections

Finland
University of Oxford
Johns Hopkins Bloomberg School of Public Health; University of Otago; Patan Academy...

Completed

PCV10 Immunogenicity Study Nepal 2015

Streptococcus Pneumoniae

United Kingdom
Sheba Medical Center
United States Agency for International Development (USAID); Maccabi Healthcare... and other collaborators

Unknown

PICR-b Nasopharyngeal S. Pneumoniae and Nasal S. Aureus Carriage Study (PICRcarriage)

Streptococcus Pneumoniae

Israel
Genocea Biosciences, Inc.

Completed

Safety and Immunogenicity Study of Prophylactic Streptococcus Pneumoniae Vaccine

Streptococcus Pneumoniae

United States

Clinical Trials on Pneumonia, Pneumococcal

Sponsors and Collaborators

Medical Conditions

Drug Interventions

CROs by country

CROs in Colombia

Conditions

Rare Diseases

Drug Interventions

Dietary Supplements

Sponsor/Collaborators

Locations